Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Net Income towards Common Stockholders (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Net Income towards Common Stockholders over the past 16 years, most recently at -$2.0 million for Q2 2025.

  • Quarterly results put Net Income towards Common Stockholders at -$2.0 million for Q2 2025, up 71.1% from a year ago — trailing twelve months through May 2025 was -$44.4 million (down 280.2% YoY), and the annual figure for FY2025 was -$44.4 million, down 469.26%.
  • Net Income towards Common Stockholders for Q2 2025 was -$2.0 million at Lifecore Biomedical, Inc. \De\, up from -$17.4 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for LFCR hit a ceiling of $15.6 million in Q1 2024 and a floor of -$51.6 million in Q2 2022.
  • Median Net Income towards Common Stockholders over the past 5 years was -$3.9 million (2022), compared with a mean of -$9.1 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: plummeted 2376.79% in 2022 and later soared 494.4% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Net Income towards Common Stockholders stood at -$46.0 million in 2021, then surged by 92.17% to -$3.6 million in 2022, then soared by 494.4% to $14.2 million in 2023, then tumbled by 161.21% to -$8.7 million in 2024, then skyrocketed by 76.48% to -$2.0 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were -$2.0 million (Q2 2025), -$17.4 million (Q1 2025), and -$8.7 million (Q4 2024) per Business Quant data.